Safety of Transcarotid Revascularization in Patients with a Contraindication to Dual Antiplatelets.

In this small series of TCARs, patients not maintained on dual antiplatelets did not experience more perioperative adverse events after TCAR. However, more studies, in larger series, are required to verify and validate these findings.